Can we eliminate placebo in ALS clinical trials?
- WW Bryan
- , RJ Hoagland
- , J Murphy
- , C Armon
- , RJ Barohn
- , JC Goodpasture
- , RG Miller
- , GJ Parry
- , JH Petajan
- , MA Ross
- , SC Stromatt
- , the rhCNTF ALS Study Group
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.